Laboratory of Molecular Imaging, Singapore Bioimaging Consortium (SBIC), A*STAR, 11 Biopolis way, Singapore 138667, Singapore.
EJNMMI Res. 2013 Aug 2;3(1):60. doi: 10.1186/2191-219X-3-60.
Gastrointestinal (GI) disorders are commonly associated with chronic conditions such as diabetes, obesity, and hypertension. Direct consequences are obstipation or diarrhea as opposite aspects of the irritable bowel syndrome, and more indirectly, alteration of appetite, feeling of fullness, flatulence, bloatedness, and eventually leading to altered absorption of nutrients. Moreover, GI retention and passage times have been recognized as important factors in determining the release site and hence the bioavailability of orally administered drugs. To facilitate the understanding of physiological and pathological processes involved, it is necessary to monitor the gut motility in animal models. Here, we describe a method for studying the GI transit time using technetium-labeled activated charcoal diethylenetriaminepentaacetic acid (99mTc-Ch-DTPA) detected by single-photon emission computed tomography (SPECT).
Tc-DTPA was adsorbed onto activated charcoal and administered orally to trypan blue-tainted (n = 4) 129SvEv mice (50 to 80 MBq/animal, n = 11). The exact distribution and movement of radioactivity in the gastrointestinal tract was measured at intervals of 1, 3, 6, 12, and 22 h by SPECT-CT. In addition, in order to validate the imaging of GI transient time, loperamide (0.25 mg/animal, n = 3) was used to delay the GI transit.
The transit time measured as the peak radioactivity occurring in the rectum was 6 to 7 h after gavaging of 99mTc-Ch-DTPA. After 1 h, the bolus had passed into the small intestine and entered the cecum and the colon. At 6 and 8 h, the cecum, the ascending, transverse, and descending colon, and the rectum showed significant labeling. Several pellets were stored in the rectum for defecation. After 22 h, little activity remained in the stomach and none was detected in the transverse colon or other GI locations. In contrast, 6 h after administration of loperamide, only the cecum and part of the transverse colon were labeled. After 22 h, both structures retained significant amount of label. This delay has been verified by non-radiolabeled dye trypan blue GI measurements (n = 4).
Here, we present the first non-invasive study of mouse GI transit time, allowing clear differentiation between vehicle- and loperamide-treated animals. This technique is useful for the investigation of GI motility in mice.
胃肠道(GI)疾病通常与慢性疾病如糖尿病、肥胖症和高血压有关。直接后果是便秘或腹泻,这是肠易激综合征的相反方面,更间接的是,改变食欲、饱腹感、胀气、腹胀感,最终导致营养吸收改变。此外,胃肠道保留和通过时间已被认为是确定口服药物释放部位和生物利用度的重要因素。为了促进对所涉及的生理和病理过程的理解,有必要在动物模型中监测肠道蠕动。在这里,我们描述了一种使用锝标记的活性碳二乙三胺五乙酸(99mTc-Ch-DTPA)通过单光子发射计算机断层扫描(SPECT)研究 GI 转运时间的方法。
Tc-DTPA 被吸附到活性碳上,并以 50 至 80MBq/动物(n = 11)的剂量口服给予经锥蓝染色的 129SvEv 小鼠(n = 4)。通过 SPECT-CT 每隔 1、3、6、12 和 22 小时测量放射性在胃肠道中的精确分布和运动。此外,为了验证 GI 短暂时间的成像,使用洛哌丁胺(0.25mg/动物,n = 3)延迟 GI 转运。
用 99mTc-Ch-DTPA 灌胃后,通过 SPECT-CT 测量的峰值放射性出现在直肠中的转运时间为 6 至 7 小时。1 小时后,团块已进入小肠并进入盲肠和结肠。在 6 和 8 小时时,盲肠、升结肠、横结肠和降结肠以及直肠显示出明显的标记。几个小球储存在直肠中以备排便。22 小时后,胃中几乎没有活性,横结肠或其他 GI 部位都没有检测到。相比之下,洛哌丁胺给药后 6 小时,只有盲肠和部分横结肠被标记。22 小时后,这两个结构都保留了大量的标记物。通过非放射性染料锥蓝 GI 测量(n = 4)验证了这种延迟。
在这里,我们首次进行了非侵入性的小鼠 GI 转运时间研究,能够清楚地区分载体和洛哌丁胺处理的动物。该技术可用于研究小鼠的胃肠道动力。